MRC — Mercator Medical SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN428.92m
- PLN197.78m
- PLN469.06m
- 85
- 60
- 44
- 70
Annual cashflow statement for Mercator Medical SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.03 | 936 | 445 | -191 | -22.8 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 8.14 | -10.2 | -110 | 106 | -4.94 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 15 | -231 | 149 | 100 | 5.57 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 38.5 | 712 | 503 | 40.8 | -0.086 |
| Capital Expenditures | -15.6 | -15.5 | -177 | -110 | -39.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.162 | -146 | -53.3 | -37.1 | 72.7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -15.4 | -161 | -230 | -147 | 33.6 |
| Financing Cash Flow Items | -8.52 | -4.23 | -0.117 | -0.015 | -0.19 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -24.6 | -166 | -334 | -1.39 | -41.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.42 | 385 | -60.2 | -116 | -7.37 |